Breast cancer risk prediction models are used to plan clinical trials and counsel women; however, relationships of predicted risks of breast cancer incidence and prognosis after breast cancer diagnosis are unknown.Using largely pre-diagnostic information from the Breast Cancer Surveillance Consortium (BCSC) for 37,939 invasive breast cancers (1996-2007), we estimated 5-year breast cancer risk (<1%; 1-1.66%; ≥1.67%) with three models: BCSC 1-year risk model (BCSC-1; adapted to 5-year predictions); Breast Cancer Risk Assessment Tool (BCRAT); and BCSC 5-year risk model (BCSC-5). Breast cancer-specific mortality post-diagnosis (range: 1-13 years; median: 5.4-5.6 years) was related to predicted risk of developing breast cancer using unadjusted C...
Purpose. Risk prediction models (RPM) in breast cancer quantify survival benefit from adjuvant syste...
<p>Age-stratified models, adjusted for age in single years, registry, year of diagnosis, mode of det...
BACKGROUND:The role of breast screening in breast cancer mortality declines is debated. Screening im...
Introduction Breast cancer is the most common cancer and the leading cause of cancer-related death i...
PurposeAccurate risk assessment is necessary for decision-making around breast cancer prevention. We...
Background: Current models for assessing breast cancer risk are complex and do not include breast de...
Background: Current models for assessing breast cancer risk are complex and do not include breast de...
Background: Several studies have proposed personalized strategies based on women's individual breast...
Background Many women with breast cancer also have a high likelihood of cardiovascul...
Detecting breast cancer in its early stages improves patient outcomes, as the disease is often more ...
BACKGROUND: The role of breast screening in breast cancer mortality declines is debated. Screening i...
Background: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
Background: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
Purpose. Risk prediction models (RPM) in breast cancer quantify survival benefit from adjuvant syste...
<p>Age-stratified models, adjusted for age in single years, registry, year of diagnosis, mode of det...
BACKGROUND:The role of breast screening in breast cancer mortality declines is debated. Screening im...
Introduction Breast cancer is the most common cancer and the leading cause of cancer-related death i...
PurposeAccurate risk assessment is necessary for decision-making around breast cancer prevention. We...
Background: Current models for assessing breast cancer risk are complex and do not include breast de...
Background: Current models for assessing breast cancer risk are complex and do not include breast de...
Background: Several studies have proposed personalized strategies based on women's individual breast...
Background Many women with breast cancer also have a high likelihood of cardiovascul...
Detecting breast cancer in its early stages improves patient outcomes, as the disease is often more ...
BACKGROUND: The role of breast screening in breast cancer mortality declines is debated. Screening i...
Background: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
Background: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
Purpose. Risk prediction models (RPM) in breast cancer quantify survival benefit from adjuvant syste...
<p>Age-stratified models, adjusted for age in single years, registry, year of diagnosis, mode of det...
BACKGROUND:The role of breast screening in breast cancer mortality declines is debated. Screening im...